FSC Wealth Advisors’s Pfizer PFE Stock Holding History

FSC Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-19,496	Closed	-$497K	–	58
2025 Q3	$497K	Sell	19,496 -1,353	-6%	-$33.4K	0.29%	45
2025 Q2	$505K	Sell	20,849 -465	-2%	-$10.8K	0.32%	42
2025 Q1	$540K	Buy	21,314 +787	+4%	+$20.6K	0.35%	40
2024 Q4	$545K	Sell	20,527 -1,030	-5%	-$27.9K	0.35%	44
2024 Q3	$624K	Buy	21,557 +8	+0%	+$233	0.45%	38
2024 Q2	$603K	Buy	21,549 +500	+2%	+$13.8K	0.45%	30
2024 Q1	$584K	Sell	21,049 -154	-0.7%	-$4.27K	0.41%	32
2023 Q4	$610K	Buy	21,203 +255	+1%	+$7.71K	0.45%	26
2023 Q3	$695K	Buy	20,948 +1,534	+8%	+$54.2K	0.72%	13
2023 Q2	$712K	Buy	19,414 +1,043	+6%	+$40.6K	0.64%	14
2023 Q1	$750K	Buy	18,371 +162	+0.9%	+$7K	1.18%	6
2022 Q4	$933K	Buy	18,209 +2,978	+20%	+$143K	1.6%	5
2022 Q3	$667K	Buy	15,231 +13,293	+686%	+$646K	6.43%	3
2022 Q2	$102K	Sell	1,938 -422	-18%	-$21.5K	0.9%	27
2022 Q1	$122K	Sell	2,360 -34	-1%	-$1.76K	0.12%	35
2021 Q4	$141K	Buy	+2,394	New	+$119K	0.1%	44

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FSC Wealth Advisors's PFE Position: Q4 2025 in Review

FSC Wealth Advisors sold out of Pfizer (PFE) in Q4 2025, closing a stake of 19,496 shares — an estimated $497K sold.

FSC Wealth Advisors first reported a position in PFE in Q4 2021 and held it in 16 quarters. The position peaked at $933K in Q4 2022. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

FSC Wealth Advisors reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
FSC Wealth Advisors sold 19,496 Pfizer shares in Q4 2025, an estimated $497K.
FSC Wealth Advisors first reported a position in Pfizer in Q4 2021 and held it in 16 quarters.
FSC Wealth Advisors's Pfizer position peaked at $933K in Q4 2022.
2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on FSC Wealth Advisors's 13F filing for Q4 2025, filed 22 Jan 2026.